Advice

Discontinuation of docetaxel (Taxotere)

The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.

Medicine details

Medicine name:
docetaxel (Taxotere)
SMC ID:
369/07
Indication:
Unresectable locally advanced squamous cell carcinoma of the head and neck
Pharmaceutical company
Sanofi-Aventis
BNF chapter
Malignant disease and immunosuppression
Submission type
Full
Status
Withdrawn
Date advice published
07 May 2007
Archive advice

The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.